相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
Xiangfeng Shen et al.
FRONTIERS IN IMMUNOLOGY (2019)
PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics
Margarita Udall et al.
DIAGNOSTIC PATHOLOGY (2018)
PD-L1 in breast cancer: comparative analysis of 3 different antibodies
Tejashree Karnik et al.
HUMAN PATHOLOGY (2018)
Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints
Tao Shi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
Ticiana A. Leal et al.
JOURNAL OF THORACIC DISEASE (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
Yusuke Okuma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
High expression of programmed cell death 1 ligand 1 in lung adenocarcinoma is a poor prognostic factor particularly in smokers and wild-type epidermal growth-factor receptor cases
Shohei Mori et al.
PATHOLOGY INTERNATIONAL (2017)
Expression of enzymes related to glucose metabolism in non-small cell lung cancer and prognosis
Alexandra Giatromanolaki et al.
EXPERIMENTAL LUNG RESEARCH (2017)
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
Veronica Huber et al.
SEMINARS IN CANCER BIOLOGY (2017)
PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes
Yayi He et al.
MEDICAL SCIENCE MONITOR (2017)
Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy
Kaiyuan Wang et al.
FRONTIERS IN IMMUNOLOGY (2017)
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer
Riki Okita et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer
X. Yan et al.
CANCER GENE THERAPY (2017)
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Shari Pilon-Thomas et al.
CANCER RESEARCH (2016)
Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer
T. Kinoshita et al.
ANNALS OF ONCOLOGY (2016)
Predictive relevance of PD-L1 expression combined with CD8+TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy
Takaaki Tokito et al.
EUROPEAN JOURNAL OF CANCER (2016)
Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases
Jong-Mu Sun et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC
Malaka Ameratunga et al.
PLOS ONE (2016)
Stromal CD8+ T-cell Density-A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer
Tom Donnem et al.
CLINICAL CANCER RESEARCH (2015)
Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers
Moon-Young Kim et al.
LUNG CANCER (2015)
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma
Wendy A. Cooper et al.
LUNG CANCER (2015)
The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade
S. J. Dovedi et al.
ONCOIMMUNOLOGY (2015)
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
Lars Henning Schmidt et al.
PLOS ONE (2015)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Programmed death ligand-1 expression in non-small cell lung cancer
Vamsidhar Velcheti et al.
LABORATORY INVESTIGATION (2014)
Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
Yang Zhang et al.
ONCOTARGETS AND THERAPY (2014)
pH sensing and regulation in cancer
Mehdi Damaghi et al.
FRONTIERS IN PHYSIOLOGY (2013)
Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
Arianna Calcinotto et al.
CANCER RESEARCH (2012)
Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study
Yan-bin Chen et al.
TUMORI (2012)
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2011)
Increased Levels of Tumor-Infiltrating Lymphocytes are Associated with Improved Recurrence-Free Survival in Stage 1A Non-Small-Cell Lung Cancer
Zachary D. Horne et al.
JOURNAL OF SURGICAL RESEARCH (2011)
A High Number of CD8(+) T Cells Infiltrated in NSCLC Tissues is Associated With a Favorable Prognosis
Xuewei Zhuang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells and dendritic cells
Patric M. Schiltz et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Lung cancer - A comparative study of metabolism related protein expression in cancer cells and tumor associated stroma
Michael I. Koukourakis et al.
CANCER BIOLOGY & THERAPY (2007)
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.
MI Koukourakis et al.
CANCER RESEARCH (2006)
分享论文
